Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is linked to a higher risk of varicose veins, especially in men, but not to major vascular diseases.

Finasteride can cause long-term side effects like sexual dysfunction and depression.

Finasteride helps reduce priapism in sickle cell anemia patients.

Genital rejuvenation is becoming popular for improving genital appearance and function in both men and women.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Finasteride reduced VEGF expression and microvascular density in diabetic mice.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Post-finasteride syndrome causes lasting sexual, mental, and physical issues, needing more research for solutions.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Finasteride may cause lasting sexual side effects, but more research is needed.

PRP injections don't significantly help with mild to moderate erectile dysfunction.

Finasteride doesn't reduce sexual function in people with hair loss.

Minoxidil can cause unexpected heart problems like chest pain.

Early onset baldness may be linked to thicker artery walls.

Men with androgenetic alopecia may have more sexual dysfunctions.

Stopping finasteride and closing PFO can help prevent strokes in young adults.

Finasteride can cause skin reactions, so dermatologists should be aware.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.

Minoxidil and nebivolol can help prevent aortic aging in diabetic mice.

Men with androgenetic alopecia may have higher cardiovascular risk due to elevated serum endocan levels.

Dutasteride and finasteride don't raise erectile dysfunction risk.

5α-Reductase inhibitors can negatively impact sexual function.

The cause of post-finasteride syndrome is unclear and needs more research.

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.

Finasteride, a hair loss drug, has unaddressed sexual side effects due to the manufacturer's inadequate safety measures and lack of additional studies.